MedPath

How to treat peri-implantitis?

Completed
Conditions
Peri-implantitis
Registration Number
NL-OMON21821
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Publications: de Waal YC, Raghoebar GM, Huddleston Slater JJ, Meijer HJ, Winkel EG, van Winkelhoff AJ. Implant decontamination during surgical peri-implantitis treatment: a randomized, double-blind, placebo-controlled trial. J Clin Periodontol. 2013;40:186-195.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
27
Inclusion Criteria

Inclusion criteria were:

•≥ 18 years of age;

Exclusion Criteria

•Contraindications for the surgical procedures;

•A history of local radiotherapy to the head and neck region;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of sites with bleeding on probing (% sites BoP) was used as primary clinical outcome variable
Secondary Outcome Measures
NameTimeMethod
Secondary clinical outcome variables were presence of plaque (% sites plaque), suppuration on probing (% sites SoP), mean PPD and radio-graphical marginal bone loss at baseline. Next to this microbiolical parameters were recorded.
© Copyright 2025. All Rights Reserved by MedPath